Julie A Wolfson MD MSHS
Pediatric Hematologic Oncology
Associate Professor, Pediatrics; Member, Institute for Cancer Outcomes and Survivorship
Join to view full profile
1600 7th Avenue SouthBirmingham, AL 35233
Phone+1 626-301-8442
Dr. Wolfson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2006 - 2010
UCLA School of Public HealthMSHS, Health Services, 2007 - 2009
Mass General Brigham/Massachusetts General HospitalResidency, Pediatrics, 2002 - 2005
University of Florida College of MedicineClass of 2002
Harvard UniversityA.B., English, 1990 - 1994
Certifications & Licensure
CA State Medical License 2006 - Present
AL State Medical License 2015 - 2026
MA State Medical License 2002 - 2008
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Treatment Adherence and Self-Management in Adolescent and Young Adult Oncology.Meghan E McGrady, Rachel Tillery Webster, Julie A Wolfson
Journal of Adolescent and Young Adult Oncology. 2026-08-01 - Adolescents and Young Adults With Acute Lymphoblastic Leukemia: Qualitative Barriers and Facilitators to Guideline-Concordant Care.Allison C Grimes, Julie A Wolfson, Charlotte L Kerber, Kristin M Bingen, Melissa P Beauchemin
Cancer Control. 2026-07-20 - 10 citationsAmerican Society of Hematology 2026 guidelines for frontline management of acute lymphoblastic leukemia in adolescents and young adults.Adam S DuVall, Jennifer McNeer, Matthew C Cheung, Diego A Adrianzen-Herrera, Anjali Advani
Blood Advances. 2026-07-14
Journal Articles
- Impact of treatment site in adolescents and young adults with central nervous system tumorsWolfson J, Sun CL, Kang T, Wyatt L, D'Appuzzo M, Bhatia S., Journal of the National Cancer Institute, 9/1/2014
Press Mentions
- How Cancer Centers Are Raising the Care GameJune 10th, 2021
Lack of Clinical Trial Participation and Shorter Duration of Therapy Linked to Disease Relapse in AYAs with LeukemiaOctober 5th, 2018
Clinical Trial Participation and Treatment Duration May Influence Risk of Relapse in Adolescent and Young Adult Leukemia PatientsSeptember 27th, 2018
Grant Support
- Predictors of Systemic Exposure to Oral 6MP During Maintenance in Adolescentsand Young Adults with Acute Lymphoblastic LeukemiaUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2027
- Paul Calabresi Career Development Award for Clinical OncologyNational Cancer Institute2011–2015
- St. Baldrick's Scholar AwardSt. Baldrick's Foundation2011–2014
Professional Memberships
- Member
- Member
- American Society of Pediatric Hematology-OncologyMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
